Introduction
The aim of treating epilepsies is to control seizures without causing adverse effects to achieve the best possible quality of life for the patient. Usually, seizure frequency is counted by subjective patient reports, which may cause considerable problems due to incorrect descriptions of seizures and their frequency. Respective controlled trials showed that seizures were only recognised in 39-49% of patients.
1,2 Nocturnal seizures are not recognised by the patients in up to 80% of cases. 3 The aim of this investigation was to present a more elaborate and objective approach for quantifying seizure frequency and duration over a time period of several months, which would not be feasible in an EMU, using first a short inpatient monitoring period followed by prolonged outpatient video-EEG/video monitoring. For the investigations, two patients were selected who represented different issues with respect to A reliable method for the estimation of seizure frequency and severity is indispensable in assessing the efficacy of drug treatment in epilepsies. These quantities are usually deduced from subjective patient reports, which may cause considerable problems due to insufficient or false descriptions of seizures and their frequency. We present data from two difficult-to-treat patients with intractable epilepsy. Pat. 1 has had an unknown number of CP seizures. Here, a prolonged outpatient video-EEG monitoring over 160 h and 137 h (over an interval of three months) was performed with an automated seizure detection method. Pat. 2 suffered exclusively from nocturnal seizures originating from the frontal lobe. In this case, an objective quantification of the efficacy of drug treatment over a time period of 22 weeks was established. For the reliable quantification of seizures, a prolonged outpatient video/video-EEG monitoring was appended after a short-term inpatient monitoring period.
Patient 1: The seizure detection algorithm was capable of detecting 10 out of 11 seizures. The number of false-positive events was <0.03/h. It was clearly demonstrated that the patient showed more seizures than originally reported. Patient 2: The add-on medication of lacosamide led to a significant reduction in seizure frequency and to a marked decrease in the mean duration of seizures. The severity of seizures was reduced from numerous hypermotoric seizures to few mild, head-turning seizures.
Outpatient monitoring may be helpful to guide treatment for severe epilepsies and offers the possibility to more reliably quantify the efficacy of treatment in the long-term, even over several months.
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clinical relevance. In one patient, it was quite unclear how many seizures the patient suffered at all. In the second patient, the seizure frequency and severity were measured after an add-on lacosamide treatment.
Method
Pat. 1 (44y, f) has suffered from symptomatic epilepsy since the age of 33. The patient usually shows hypomotoric CP seizures, but rarely, SGTC seizures are observed. Before investigation, the assumed number of CP seizures was approximately 5 per month. No clear lesion was detected in the MRI, but the suspicion of a cortical heterotopia was reported.
The simultaneous video-EEG recording started as an inpatient monitoring period at our epilepsy centre for three days using the 10-20 system and 2 ECG channels (64 channels, sampling rate 256 Hz, Neurofile XP System, ITmed, Usingen). Following this short inpatient monitoring period, a prolonged outpatient monitoring period of seven days (with a recording time of approximately 169 h) was employed using the portable Epi-Home system (ITmed, Usingen) in a nearby hotel. This system included a laptop computer, a 38-channel EEG-amplifier (sampling rate 256 Hz), a special camera for audio/video, and an infrared-lamp for video recording during nights. This setup was installed near the bedside (see Fig. 1 ). The scalp electrodes were glued to provide good recording conditions. During outpatient monitoring, a medical assistant went to the hotel every day and serviced the electrodes. The recorded video-EEG data from the previous day were transferred via an external USB hard drive from the portable video-EEG system to the main database in the hospital. Here, the entire set of EEG data (typical 24 h) was first analysed offline using an automated seizure detection program that was recently developed at our hospital. This fast and robust program provides high sensitivity and an acceptably low rate of false-positive events for scalp-EEG recordings. The program is also routinely used clinically for presurgical evaluation. Details of the algorithm, which is essentially based on spectral analysis techniques using special detection montages for two frequency bands, 3-12 Hz and 12-18 Hz, and seizure detection performance can be found in Ref. [4] . In addition to automated seizure detection, a visual inspection of the data was made by experts. The duration of the electrographical seizure pattern was determined visually from the EEG and semi-automatically from the integrated power. 4, 5 The outpatient monitoring in the hotel was repeated again after 3 months for approximately 5 days (recording time 137 h) using the same procedure described above. In total, 297 h of outpatient video-EEG data were analysed. The second patient (Pat. 2) suffers from difficult-to-treat cryptogenic frontal lobe epilepsy exhibiting frequent hypermotoric nocturnal seizures, which he usually did not recognise. The primary goal was to investigate the efficacy of drug treatment over more than 22 weeks using prolonged outpatient monitoring. The clinical characteristics of the patient were as follows: male, age 29 years, 105 kg body weight, epilepsy since age 21, normal MRI. A routine EEG showed alpha activity with intermittent theta activity and frontal spikes; ictal SPECT showed a hyperperfusion frontal right lobe. The neurological examination was normal. Seizure semiology was as follows: turning of the head to the left side, flexing of the trunk and hypermotoric movement of the extremities for several minutes occurring during sleep 40-50 times per night. Because of the excessive hypermotoric movements, injuries have occurred several times.
Previous treatment consisted of different anticonvulsive drugs, including valproate (VPA), oxcarbazepine (OXC) and pregabaline (PGB). The titration scheme of anticonvulsive drugs during longterm monitoring over a period of 21 weeks is shown in Table 1 . During this period, lacosamide was added while the dosage of OXC and PGB was kept nearly constant (in week 16, the daily dosage of OXC (mg) 900-0-900 900-0-900 900-0-900 900-0-900 900-0-900 900-0-900 900-0-900 900-0-900 900-0-900 900-0-900 900-0-900 PGB (mg) 300-0-300 300-0-300 300-0-300 300-0-300 300-0-300 300-0-300 300-0-300 300-0-300 300-0-300 225-0-300 225-0-300 LCM PGB was slightly reduced from 600 to 525 mg). Repeated measurements of serum concentrations of the anticonvulsive drugs were taken. The simultaneous video-EEG recording started as an inpatient monitoring period at our epilepsy centre for two weeks (week 1 and 3) using the extended 10-20 system (29 EEG channels, 2 ECG channels). Subsequent to the inpatient monitoring period, a prolonged outpatient home monitoring period was employed using the portable Epi-Home system mentioned previously. Most of the home monitoring consisted only of video recording of the patient's seizures during the night because no seizure pattern had been seen in the EEG. The video was examined carefully by the parents of the patient (the father is a scientist), and all seizures were well documented with respect to their frequency and severity. On one weekend (week 21), both video and an EEG were recorded. The video and the EEG data were again analysed by experienced epileptologists.
In addition, thorough neuropsychological testing was performed on Pat. 2. These standardised tests included performance on tests of information-processing speed, verbal and figural memory, topologic memory, incidental memory, concentration and attention.
Results
During the short inpatient monitoring period, Pat. 1 showed neither clinical/subclinical seizures nor pathological activity in the EEG. In the subsequent outpatient monitoring period in the hotel, the patient showed four hypomotoric complex partial seizures during the daytime. These seizures were correctly identified by the automated seizure detection program for the frequency band 3-12 Hz, (in the band 12-18 Hz, only two seizures were found). No additional seizures were found by visual inspection. The number of false-positive events in both frequency bands was <0.02/h (corresponding to approximately one false detection in 50 h).
For illustration, Fig. 2 shows the integrated power (IP) and the seizure detection value (SDV) for the 3-12 Hz frequency band over one day. During the second outpatient monitoring period in the hotel (after 3 months), the patient showed seven seizures (presumably six clinical and one subclinical, during sleep). At one session a medical assistant was present while the patient suffered a complex partial seizure. Due to the testing procedure, it turned out that the patient did not notice the seizure at all. The automated seizure detection program correctly found six seizures in the frequency band 1. One seizure was missed because the duration of the corresponding EEG activity was too short (duration 7-8 s); this seizure was identified by visual inspection. The number of false-positive events for all data (137 h) was <0.03/h in both frequency bands. Fig. 3 summarises the corresponding durations of each seizure estimated from the EEG activity. On average, the duration of the electrographical seizures was longer during the first outpatient monitoring period than during the second one.
Next, the results of patient 2 are presented. During inpatient monitoring, the patient displayed many nocturnal seizures with strong hypermotoric activity. The corresponding EEG showed only artefacts due to the patient's movement. No seizure pattern was detected in the EEG before and during visible seizures (this was the reason for not using an automated seizure detection program). The time course of seizure frequency and the mean duration of seizures during the uptitration of lacosamide is shown in Fig. 4 . There was a significant reduction of seizure frequency and duration, dropping from 133 nocturnal seizures and a mean duration of 50 s in the first week to 57 seizures and a mean seizure duration of 14 s in the ninth week. In this treatment phase, lacosamide was added to oxcarbazepine and pregabaline, using up to 400 mg in the ninth week. During the following weeks (10th-22nd), the dosage of lacosamide was increased to 600 mg per day. This led to a further decrease in seizure frequency (e.g. 19 seizures in 22nd week), whereas the mean duration of seizures slightly increased. Interestingly, a decrease in the severity of the seizures, from severe hypermotoric seizures to motor and slight, head-turning seizures, was also observed. The serum concentration for lacosamide at the end of the observation period (600 mg LCM) was 9.7 mg/ml. No side effects of medication were reported by the patient. Repeated ECG measurements were normal.
Neuropsychological examination over the course of four tests at different times (Table 1) showed a slight improvement in incidental and topologic memory performance. Selective attention remained above average, whereas concentration was below average in all tests. Verbal and figural memory were slightly below average in all tests and did not show any significant changes.
Discussion
Concerning the actual seizure frequency of Pat. 1, the prolonged outpatient video-EEG monitoring in the hotel at two different time intervals clearly demonstrated that the patient actually suffered more seizures than counted by herself or her relatives. Furthermore, the electroclinical seizure duration varied between both monitoring periods. Of course, it was impossible to estimate the clinical duration of the seizures because, without one exception, no adequate testing could be performed. Therefore, only the duration of the seizure activity estimated from the EEG might provide some hints about the actual duration of seizures.
It is noteworthy that the seizure detection algorithm using standardised parameters was capable of correctly detecting 10 of 11 seizures, whereas the number of false-positives was quite low (approximately 0.03/h over 297 h). The important point is that the automated seizure detection, including the fast review capability of the compressed display of the integrated power, provided a significant reduction in the time needed for analysing the huge amount of video-EEG data during outpatient monitoring where no observer was present, as in EMUs.
In Pat. 2, with difficult-to-treat epilepsy, the efficacy of add-on treatment by means of lacosamide could be objectively documented in a long-term follow up by in-and outpatient monitoring over a time period of five months. To our knowledge, this is the first investigation of this kind to be performed. In addition to a significant reduction in seizure frequency and the mean duration of seizures, the severity of seizures also decreased markedly. After a dosage of 600 mg lacosamide, intense hypermotor seizures stopped completely and only a few minor motoric events with turning of the head persisted. This effect might be attributed simply to the add-on of lacosamide because the dosage of OXC and PGB were essentially constant during the observed time period. Long-term monitoring results over several months, as well as cognitive testing, were used to guide further stepwise dosage decisions. In this case, in-and outpatient home-monitoring therefore proved to be very helpful for guiding the treatment of this severe epilepsy, which otherwise would be much more difficult to treat.
Conclusion
We presented data from two difficult-to-treat epilepsy patients. In one case, it was important to determine the actual seizure frequency. In the other case, we sought to objectively quantify the efficacy of medication on a prolonged time scale. Both issues may be sufficiently addressed only by using prolonged outpatient video-EEG monitoring in combination with an efficient and robust automated seizure detection method. We are aware that only two patients were investigated, and thus, our approach is more or less a feasibility study. In the future, more patients should be investigated to demonstrate the usefulness of outpatient monitoring, both in acute cases and prolonged monitoring cases lasting several months.
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